Abstract 3594: Adaptively randomized seamless-phase multiarm platform trial: Glioblastoma Multiforme Adaptive Global Innovative Learning Environment (GBM AGILE)
Donald A. Berry(Berry & Associates (United States)), Scott Berry(Queen's University), Brian M. Alexander(Brigham and Women's Hospital), Anna D. Barker(Arizona State University), Todd Graves(Abington Memorial Hospital), Jason Connor(Newberry College), Timothy F. Cloughesy(University of California, Los Angeles)
Cited by 2
Related Papers
Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct
|New England Journal of Medicine|2017|5.5k
Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis
|JAMA|2019|1.5k
Molecular Determinants of the Response of Glioblastomas to EGFR Kinase Inhibitors
|New England Journal of Medicine|2005|1.4k
Revision of the American Joint Committee on Cancer Staging System for Breast Cancer
|Journal of Clinical Oncology|2002|1.2k